Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
Translational Lung Cancer Research|November 29, 2023
Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifierYingran Shen, Chandra Goparaju, Yang Yang, et al.Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|October 27, 2018
Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantationMasashi Kawabori, Chitaru Kurihara, Ryan T Conyer, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 5, 2020
Safety of patients and providers in lung cancer surgery during the COVID-19 pandemicStephanie H Chang, Michael Zervos, Amie Kent, et al.Carcinogenesis|November 9, 2014
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survivalFrancine Baumann, Erin Flores, Andrea Napolitano, et al.American Journal of Industrial Medicine|January 28, 2016
Reduced lung function in smokers in a lung cancer screening cohort with asbestos exposure and pleural plaquesSarah Lopatin, Jun-Chieh Tsay, Doreen Addrizzo-Harris, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sexAnn G Schwartz, Geoffrey M Prysak, Valerie Murphy, et al.Advanced Materials (Deerfield Beach, Fla.)|October 23, 2018
Construction of a Novel Bispecific Antibody to Enhance Antitumor Activity against Lung CancerWei Yin, Junjie Zhu, Diego Gonzalez-Rivas, et al.Diagnostic Cytopathology|November 6, 2009
The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathyWei Sun, Kunchang Song, Michael Zervos, et al.Plos One|December 23, 2015
Inflammasome Modulation by Chemotherapeutics in Malignant MesotheliomaCatherine Westbom, Joyce K Thompson, Alan Leggett, et al.Plos One|July 5, 2012
Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cellsKheng Newick, Brian Cunniff, Kelsey Preston, et al.Pageof 11